RxDoctor Payments DataLook up a doctor →

Rekha Gandhi, MD

Neurology · Winter Park, FLNPI 1376703876

Payments from drug & device makers

$13,367,124in general payments, 2019–2025

Across 530 payments — averaging $25,221 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$6.8M
  • AbbVie$2.5M
  • Novartis$1.5M
  • E.r. Squibb & Sons, L.L.C.$1.1M
  • Janssen Research & Development, LLC$761K
  • Sage Therapeutics, LLC$273K
  • plus $488K from 35 others
$503,921in research payments, 2019–2025

Across 9 payments — averaging $55,991 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$504K

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$13,367,124 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida

Medicare billing

Part B allowed, 2024
$69,605
Medicare patients
215
Services billed
651

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Winter Park

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →